EXOSC5

EXOSC5 (hRrp46) is a structural subunit of the RNA exosome complex required for normal RNA processing and development (PMID:32504085). The human protein forms homodimers both as a recombinant protein and in cellular extracts and binds DNA, but lacks detectable intrinsic nuclease activity, in contrast to the rice ortholog oRrp46 whose dimeric form possesses both phosphorolytic RNase and hydrolytic DNase activities dependent on identified catalytic and substrate-binding residues (PMID:20660080). Pathogenic missense variants modeled in yeast and mammalian cells disrupt RNA exosome function and alter interactions with other exosome subunits, and loss of exosc5 in zebrafish produces developmental abnormalities including shortened/curved bodies and reduced head and eye size, establishing a required developmental role (PMID:32504085). The direct molecular link between EXOSC5's exosome function and the downstream proliferative and stemness phenotypes reported in cancer contexts has not been characterized in the available corpus.

1. 2010 High

   It was unknown whether human Rrp46 carried intrinsic catalytic activity or behaved purely as a structural subunit; comparison of the human protein with the rice ortholog established that human EXOSC5 dimerizes and binds DNA but lacks nuclease activity, whereas the catalytic machinery is preserved and structurally defined in the plant ortholog.

   Evidence X-ray crystal structure of rice Rrp46 at 2.0 Å, site-directed mutagenesis of catalytic residues, in vitro nuclease assays, and homodimerization Co-IP in human cell extracts

   PMID:20660080

   Open questions at the time

   • No structure of the human EXOSC5 protein itself
   • Why human EXOSC5 lacks the nuclease activity retained in the rice ortholog is not resolved
   • Functional consequence of EXOSC5 homodimerization independent of the exosome is undefined
2. 2020 Medium

   It was unknown whether EXOSC5 variants cause human disease and how they affect the exosome; modeling of patient missense variants and zebrafish loss-of-function established EXOSC5 as a structural exosome subunit whose disruption impairs exosome function, alters inter-subunit interactions, and is required for normal development.

   Evidence Yeast and mammalian cell modeling of patient variants, RNA exosome functional and interaction assays, and zebrafish loss-of-function

   PMID:32504085

   Open questions at the time

   • Specific RNA substrates mis-processed upon EXOSC5 disruption not defined
   • Tissue-specific basis of the neurodevelopmental phenotype unresolved
   • Quantitative effect of each variant on exosome assembly not separated from activity defects
3. 2022 Low

   It was unknown whether EXOSC5 influences tumor cell proliferation; knockdown in gastric and hepatocellular carcinoma cells linked EXOSC5 to cell cycle progression and STAT3/AKT signaling, placing it upstream of proliferative pathways in cancer.

   Evidence siRNA knockdown with Western blot, proliferation/colony formation assays, flow cytometry cell cycle analysis, and xenografts in gastric and HCC cells

   PMID:35371329 PMID:36293016

   Open questions at the time

   • No mechanistic reconstitution connecting exosome function to STAT3/AKT
   • Single-lab knockdown studies without rescue or direct molecular interaction data
   • Whether the effect depends on exosome RNA processing is untested
4. 2024 Low

   It was unknown how EXOSC5 might support cancer stem cell behavior; knockdown in endometrial cancer cells reduced NTN4 expression and placed EXOSC5 upstream of an NTN4/integrin β1/FAK/SRC/c-MYC self-renewal axis.

   Evidence siRNA knockdown, exogenous NTN4 rescue, Western blot, tumor sphere assays, and in vivo tumorigenicity assays

   PMID:38164180

   Open questions at the time

   • No direct binding or reconstitution of EXOSC5 within the NTN4 pathway
   • Mechanism by which an exosome subunit controls NTN4 transcript or protein levels unknown
   • Single-lab pathway-placement study

• The direct molecular mechanism connecting EXOSC5's RNA exosome function to the downstream STAT3 and NTN4/integrin β1 signaling outputs observed in cancer remains unresolved.
• No RNA substrate identified that bridges exosome activity to these signaling pathways
• No reconstitution or direct interaction data linking EXOSC5 to the cancer pathways
• Whether oncogenic effects require an intact exosome complex is untested